|
|
Blood, 15 April 2007, Vol. 109, No. 8, pp. 3128-3129.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS
Comment on Zou et al, page 3284
Inside-out, outside-in: what's the difference?
Edward F. Plow, and
Yan-Qing Ma
1 CLEVELAND CLINIC
Zou and colleagues use retrovirus infection and fetal liver transplantation to engineer platelets in mice expressing  IIbß3 and use point mutations to dissect inside-out and outside-in signaling in vivo.
As if integrin nomenclature were not complicated enough, with all its alphas and betas, we must now be cognizant of the subtleties of an additional layer of terminologies, "inside-out" and "outside-in" signaling. There is, of course, a logic to integrate these additional terms into our integrin vocabulary: they define distinct and biologically important aspects of integrin-mediated cellular responses. IIbß3 is the integrin that mediates platelet aggregation, and its ability to form a stable thrombus in vivo depends upon both inside-out and outside-in signaling. Engagement of fibrinogen or von Willebrand factor by the extracellular domain of IIbß3 is necessary for platelet aggregation and requires a conformational transition, the consequence of inside-out signaling. As platelets aggregate, occupied IIbß3 integrins cluster and trigger outside-in signaling that stabilizes the aggregate and supports responses, including platelet spreading and clot retraction. Hence, inside-out and outside-in signaling constitute the 2 elements of the bidirectional signaling across IIbß3 (see figure) and represent potential antithrombotic therapeutic targets, and their dissection is indispensable to our understanding of platelet biology.
The inside-out and outside-in signaling pathways ultimately trace to cytoplasmic tails (CTs) of IIbß3, which serve as receivers and transmitters of bidirectional signaling within the receptor. While the CTs of the IIb and ß3 subunits are short, they are structurally complex and interact with numerous binding partners. Ordinarily, the contribution of specific structural elements or individual amino acids can be dissected by straightforward mutagenesis. However, platelets are anucleated; and alternative approaches have had to be invoked to examine inside-out and outside-in signaling. These approaches have included the following: (1) expression of IIbß3 in heterologous cells; (2) transfection of the primary megakaryocytes; (3) introduction of membrane-permeable peptides into platelets; and (4) generation of knock-in mice expressing mutant IIbß3. Each of these approaches has been used successfully to probe integrin signaling, but each approach has inherent limitations.
By infecting fetal liver cells from ß3-deficient mice with retrovirus engineered to encode wild-type ß3-subunit and transplanting these cells into irradiated recipients, Zou and colleagues show that these cells can successfully express IIbß3 and rescue both inside-out and outside-in signaling in blood platelets. This strategy is then used to introduce specific mutations into the mouse platelets. Inside-out signaling is evaluated by the capacity of the platelets to bind soluble fibrinogen, and outside-in signaling is assessed by platelet spreading. A single point mutation in the midregion of the ß3 CT, ß3Y747A, prevents restoration of both inside-out and outside-in signaling, while a point mutation at the extreme C-terminus of ß3, ß3T762A, results in selective loss of outside-in signaling. These results are generally consistent with those derived from the other approaches we outlined and fortify the conclusion that different sites within the ß3 CT can mediate different aspects of the bidirectional signaling.
The experimental approach for in vivo expression in platelets described by Zou et al here and by others1 allows analyses of IIbß3 activation in platelets in vivo and has high throughput potential. Fetal liver transplantation could undoubtedly be applied to other platelet proteins provided that a deficient mouse background is available. Low, variable, and unstable expression of the platelet protein may set limitations on this approach. Nonetheless, the Zou et al paper sets the precedent for a new strategy to dissect inside-out and outside-in signaling across IIbß3 in vivo.
Footnotes
The authors declare no competing financial interests. 
REFERENCES
- Fang J, Hodivala-Dilke K, Johnson BD, et al. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. Blood 2005; 106:2671–2679.[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Structure-function analysis reveals discrete ß3 integrin inside-out and outside-in signaling pathways in platelets
- Zhiying Zou, Hong Chen, Alec A. Schmaier, Richard O. Hynes, and Mark L. Kahn
Blood 2007 109: 3284-3290.
[Abstract]
[Full Text]
[PDF]
|
|
